Director, National Thought Leader Liaison jobs in United States
cer-icon
Apply on Employer Site
company-logo

Nuvalent, Inc. · 18 hours ago

Director, National Thought Leader Liaison

Nuvalent is an exciting early-stage company focused on creating selective medicines for cancer patients. The Director, Thought Leader Liaison will lead the engagement strategy with key thought leaders in lung cancer, ensuring alignment with brand objectives and supporting the commercial launch readiness of new products.

BiotechnologyLife ScienceTherapeutics

Responsibilities

Develop and execute a comprehensive Commercial engagement strategy for lung cancer thought leaders, including academic researchers, digital opinion leaders, and other key influencers
Collaborate with internal teams to implement commercial strategies and manage interactions with key accounts, ensuring alignment with Nuvalent’s business goals
Capture valuable therapeutic and competitive insights from Thought Leaders and other key stakeholders to guide impactful field insights integration that shapes positioning, messaging, and stakeholder engagement strategies
Work closely with the Senior Director, Thought Leader Strategy to aggregate insights and determine implications to the brand and disseminate as part of the Insights Team
Work closely with internal teams to execute commercial launch strategies, managing interactions with Thought Leaders throughout the process
Identify and engage promotional speakers to represent Nuvalent at regional and national events
Identify and nominate promotional speakers for the brand Speaker Bureau
Cultivate and maintain strong, trusting relationships with Thought Leaders, ensuring they are well-informed about Nuvalent’s activities, portfolio, and strategic direction
Partner with Legal and Compliance teams to enforce guidelines and processes for compliant customer engagement
Serve as a point of coordination, facilitating connectivity across internal stakeholders in collaboration efforts to become a preferred industry partner
Co-lead and execute Commercial Advisory Boards in partnership with Head, Thought Leader Strategy and internal cross-functional collaborators
Execute the Thought Leader Engagement Congress strategy
Support brand initiatives with KOL needs (ie. KOL videos, Peer to Peer programs, Product theaters)
Compliantly support Field needs to include, but not limited to: KOL introductions, speaker bureau nominations, KOL expert panels at sales meetings

Qualification

Oncology launch experienceThought Leader LiaisonCommercial oncology experienceBiopharma experienceOperations toolsAnalytical skillsLeadership skillsCommunication skillsInterpersonal skillsCollaboration skills

Required

Bachelor's degree. Advanced degree preferable
10+ years biopharma experience including oncology launch experience
5+ years as a Thought Leader Liaison in Oncology
5+ years of commercial oncology experience in the U.S. market, with expertise in sales, marketing, or related functions
Demonstrated ability to manage multiple projects simultaneously, prioritize effectively, and communicate across all organizational levels
Proven track record of recruiting, onboarding, managing, coaching, and retaining top talent, with strong leadership and mentorship skills
Strong understanding of analytics and operations tools/technologies
Excellent written and verbal communication skills, including presentation abilities
Willingness to travel up to 50% domestically

Preferred

Experience in Lung cancer is highly preferrable
Prior Thought Leader Liaison engagement and/or scientific exchange in Lung Cancer

Benefits

Medical, dental, and vision insurance
401(k) retirement savings plan
Generous paid time off (including a summer and winter company shutdown)

Company

Nuvalent, Inc.

twittertwittertwitter
company-logo
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Funding

Current Stage
Public Company
Total Funding
$1.82B
Key Investors
Bain Capital Life SciencesDeerfield
2025-11-18Post Ipo Secondary· $500M
2024-09-16Post Ipo Equity· $575M
2023-10-16Post Ipo Equity· $300M

Leadership Team

leader-logo
James Porter
CEO
linkedin
leader-logo
Alexandra Balcom
Chief Financial Officer
linkedin
Company data provided by crunchbase